The custom research arm of Biocon, Syngene, has appointed Peter Bains as its Chief Executive Officer (CEO). The company announced his appointment in a filing to BSE. He was earlier a Director with the company since 2011. The company plans to file a prospectus for listing Syngene soon.

Read the Economic Times news report here.